Abstract
The plasmid DNA pERilox4 containing the gene of the recombinant protein, which included the leader sequence and the oxytocinoyl lysine tetramer, was constructed. The high level of gene expression in E. coli was achieved. The method for purification of the recombinant protein and its isolation in the soluble form was developed. The conditions for digestion of the hybrid protein by trypsin and carboxypeptidase B were matched. The effective method for transformation of oxytocinic acid to oxytocin was worked out. The scheme suggested allowed obtaining oxytocin in high yield.
Keywords: oxytocin, hybrid protein enzymatic cleavage, c-terminal amide
Protein & Peptide Letters
Title: Production And Purification Of Recombinant Human Oxytocin Overexpressed As A Hybrid Protein In Escherichia Coli
Volume: 10 Issue: 4
Author(s): Roman S. Esipov, Larisa A. Chupova, Sergey V. Shvets, Dmitry V. Chuvikovsky, Alexandr I. Gurevich, Tatyana I. Muravyova and Anatoly I. Miroshnikov
Affiliation:
Keywords: oxytocin, hybrid protein enzymatic cleavage, c-terminal amide
Abstract: The plasmid DNA pERilox4 containing the gene of the recombinant protein, which included the leader sequence and the oxytocinoyl lysine tetramer, was constructed. The high level of gene expression in E. coli was achieved. The method for purification of the recombinant protein and its isolation in the soluble form was developed. The conditions for digestion of the hybrid protein by trypsin and carboxypeptidase B were matched. The effective method for transformation of oxytocinic acid to oxytocin was worked out. The scheme suggested allowed obtaining oxytocin in high yield.
Export Options
About this article
Cite this article as:
Esipov S. Roman, Chupova A. Larisa, Shvets V. Sergey, Chuvikovsky V. Dmitry, Gurevich I. Alexandr, Muravyova I. Tatyana and Miroshnikov I. Anatoly, Production And Purification Of Recombinant Human Oxytocin Overexpressed As A Hybrid Protein In Escherichia Coli, Protein & Peptide Letters 2003; 10 (4) . https://dx.doi.org/10.2174/0929866033478807
DOI https://dx.doi.org/10.2174/0929866033478807 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting
Current Molecular Pharmacology Type 2 Diabetes: An Atherothrombotic Syndrome
Current Molecular Medicine Full Length and Delta Lactoferrin Display Differential Cell Localization Dynamics, but do not Act as Tumor Markers or Significantly Affect the Expression of Other Genes
Medicinal Chemistry Targeting Autophagy in the Brain: A Promising Approach?
Central Nervous System Agents in Medicinal Chemistry Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Distinct Modulation of Wild-Type and Selective Gene Mutated Vitamin D Receptor by Essential Polyunsaturated Fatty Acids
Mini-Reviews in Medicinal Chemistry First Steps Towards a Vaccine against Acinetobacter baumannii
Current Pharmaceutical Biotechnology Transplantation of Adipose Tissue-Derived Stem Cells for Treatment of Focal Cerebral Ischemia
Current Neurovascular Research Interactions of Cnidarian Toxins with the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase. 2. Investigation of the Carboxamide Portion of Spirocyclic Piperidine Amides
Letters in Drug Design & Discovery State-of-the-Art Methodologies for the Discovery and Characterization of DNA G-Quadruplex Binders
Current Pharmaceutical Design Lymphangiogenesis and Anti-Tumor Immune Responses
Current Molecular Medicine Utility of γH2AX as a Molecular Marker of DNA Double-Strand Breaks in Nuclear Medicine: Applications to Radionuclide Therapy Employing Auger Electron-Emitting Isotopes
Current Radiopharmaceuticals Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors
Current Neuropharmacology Possible Role of BDNF-Induced Microglial Intracellular Ca<sup>2+</sup> Elevation in the Pathophysiology of Neuropsychiatric Disorders
Mini-Reviews in Medicinal Chemistry Advances in the Methodologies for the Analysis of Acute Kidney Injury Biomarkers
Recent Patents on Biomarkers Bench to Bedside Targeting of FLT3 in Acute Leukemia
Current Drug Targets Ventilation Therapy for Patients Suffering from Obstructive Lung Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Recent Progress on Antifungal Drug Development
Current Pharmaceutical Biotechnology